Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we will assume that you are happy to receive all cookies and you will not see this message again. Click 'Find out more' for information on how to change your cookie settings.

Oxford Dementia Drug Discovery Institute (ODDI)

Oxford has one of three flagship Drug Discovry Institutes funded by Alzheimer’s Research UK. The team at Oxford is developing multiple projects to identify new therapeutic targets in Alzheimer's, Parkinson's and motor neuron disease. Professor Richard Wade-Martins is the Parkinson’s research lead on this £10M project.